How good is the evidence underlying NCCN treatment guidelines?
Centers for Medicare & Medicaid Services (CMS) and most private payers in the U.S. have accepted the NCCN guidelines as a mandated reference to determine payment for “off‐label” use of anticancer drugs that are not approved for the specific indication by the U.S. Food and Drug Administration. Thus, a key question is what types of…